Skip to Content

Join the 'Lumizyme' group to help and get support from people like you.

Lumizyme News

FDA Expands Approval of Lumizyme to treat Pompe Disease Patients of All Ages

Posted 6 Aug 2014 by

August 1, 2014 – The U.S. Food and Drug Administration today announced the approval of Lumizyme (alglucosidase alfa) for treatment of patients with infantile-onset Pompe disease, including patients who are less than 8 years of age. In addition, the Risk Evaluation and Mitigation Strategy (REMS) known as the Lumizyme ACE (Alglucosidase Alfa Control and Education) Program is being eliminated. ...

Ask a Question

Further Information

Related Condition Support Groups

Pompe disease

Lumizyme Patient Information at